Gene: KRAS ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.150 GeneticVariation disease BEFREE Medullary thyroid carcinoma (MTC), a neuroendocrine tumor originating from thyroid parafollicular cells, has been demonstrated to be associated with mutations in RET, HRAS, KRAS and NRAS. 26718898 2016
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.150 GeneticVariation disease BEFREE In addition, MC had a higher MMRd rate (0.892, 95% CI 0.758-0.956), higher BRAF(V600E) mutation rate (0.652, 95% CI 0.143-0.954) and lower KRAS mutation rate (0.171, 95% CI 0.065-0.378) than PDA/UDA and conventional adenocarcinoma. 27001432 2016
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.150 GeneticVariation disease BEFREE Recent results from exome sequencing indicate that, besides mutations in RET, HRAS, and KRAS, no other recurrent driver mutations are present in MTC. 26285815 2015
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.150 Biomarker disease BEFREE Relatively few mutations overall and no commonly recurrent driver mutations other than RET, HRAS, and KRAS were seen in the MTC exome. 23264394 2013
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.150 GeneticVariation disease BEFREE BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort. 18383861 2008
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.150 GeneticVariation disease CLINVAR